A Phase 2, Randomized, Double-blind, Placebo-controlled, Proof of Concept Trial for OPC-131461 in Patients Hospitalized for Worsening Heart Failure With Laboratory Evidence of Incomplete Decongestion Following Urgent Decongestive Therapy
Latest Information Update: 03 Feb 2025
Price :
$35 *
At a glance
- Drugs OPC-131461 (Primary)
- Indications Heart failure
- Focus Proof of concept; Therapeutic Use
- Sponsors Otsuka Pharmaceutical Development & Commercialization
- 03 Feb 2025 New trial record